President Biden has unveiled the first part in his two-part plan for rescue and economic recovery—the American Rescue Plan. He is expected to lay out part two – the Build Back Better Recovery Plan, next month. The $1.9 trillion American Rescue Plan is intended to address immediate COVID-19 needs, while the Build Back Better Recovery […]
Issuing a regulatory freeze is standard practice for an incoming administration, so as expected, shortly after President Biden was sworn in on January 20, the White House issued a memo directing agencies to freeze for 60 days any agency rules or guidance issued by the Trump administration that have not taken effect by Inauguration Day. […]
Following his inauguration on January 20, President Biden signed 17 executive orders — including several aimed at COVID-19 and others overturning a number of President Trump’s previous executive orders and policies. The January 20 orders included a mask mandate for all federal properties and for interstate travel, rejoining the World Health Organization, reinstating the Global […]
Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the University of Utah, the University’s David Eccles School of Business is now accepting applications to join its Master of Business Creation (MBC) program for 2021-2022. The priority application deadline is Feb. 12, 2021. This nine-month, professional-degree program […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS). “The management of […]
Ready to expand your company’s visibility and partnership opportunities beyond borders in 2021? Join the Innovation Stage, BIO Digital’s new interactive forum showcasing the hottest companies in biotech! How does it work? Fast-paced presentations and networking allow you to showcase your company, biotech region, or technology to a global audience of prospective partners ahead of […]
Presented by BioUtah and the Salt Lake Chamber on January 15, 2021, this webinar provided a briefing with biopharmaceutical industry experts to discuss the science behind the development of COVID-19 vaccines, the regulatory process to ensure they’re safe and effective and an update on Utah’s participation in COVID-19 clinical trials.
Press Release Courtesy of Gentex ZEELAND, Mich., Jan. 12, 2021 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX) today announced the acquisition of a new nanofiber sensing technology capable of detecting a wide variety of chemicals, from explosives to volatile organic compounds, with widespread application in a multitude of industries. Gentex is a long-time supplier of electro-optical products for the global […]
PPP loans have been reopened with an infusion of $284 billion for First Draw and Second Draw loans. First Draw loan applications will be accepted from January 11, 2021 to March 31, 2021. Second Draw applications begin January 13, 2021, until March 31, 2021. To promote access for smaller lenders and their customers, SBA will […]
On January 14th, January 26th, and February 2nd, don’t miss this series with the United States – Mexico Chamber of Commerce on the life sciences industry. Beginning on January 14th, join the video conference on Mexico’s Economic and Political Outlook. Following that, January 26th will cover Mexico’s Pharma, Biotech and Medical Devices Sectors, and February […]
Apply to Present at BIO-Europe Spring® Digital NEW deadline to apply is January 20. View Presentation Options Attracting visibility as a presenting company has never been easier at BIO-Europe Spring Digital! While presenting at a digital event may be different than what you are used to in person, it does provide new opportunities for […]
Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]
Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update. Proceeds from this transaction totaled approximately $31.9 million. The combined, publicly traded company is operating under the name Clene Inc., and its common stock began trading on the NASDAQ Capital Market on […]
Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression and improving health outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). This first of its kind program is expected to improve patient outcomes and provide meaningful cost reductions for healthcare providers and […]
We’ve received more information on channels for vaccine distribution with some positive developments
This report offers a high-level overview focused mainly on the pharmaceutical industry, related capital events – incl. investments in biotech and medtech companies – FDI flows, the biggest players in the field, and the key trends in life sciences. Read the full report below: LS & Phamaceuticals Industry Report
Co-Diagnostics has announced that it has completed principal design work for a PCR test that would allow researchers to identify certain mutations in a newly detected variant of SARS-CoV-2 known as VUI 202012/01. The new coronavirus strain comprises several mutations and may be more contagious than its predecessors. London and the southeast of Great Britain […]
Vertex has announced FDA approval of eligibility for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include people with cystic fibrosis (CF) ages 12 years and older with certain mutations in the CFTR gene. SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) and KALYDECO® (ivacaftor) also received approvals to include additional responsive mutations in people with CF ages 6 years and older and age 4 […]
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform. This new offering follows a fund raise in 2019 of more than $1.1 million via Netcapital. Proceeds from this latest campaign will further support the development […]
Article courtesy of Business Wire December 21, 2020 10:00 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Phoenix PharmaLabs, a privately held, preclinical drug company dedicated to developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform: https://netcapital.com/companies/phoenix. Proceeds from this campaign will further […]
Today the State of Utah released updated plans for First Wave of Phase 2 COVID-19 Vaccine Distribution. Notably the press release states that “Prioritization based on an individual’s employment status in certain industries is no longer being considered by the Unified Command group”.
BioUtah joined numerous patient advocates and healthcare providers in sending a letter to U.S. House and Senate leaders in opposition to the Trump administration’s Most-Favored-Nation (MFN) drug pricing rule. The letter, organized by The Part B Access for Seniors and Physicians (ASP) Coalition, stated that the MFN model for Medicare Part B drugs will “lead […]
ReddyPort has announced it has raised Seed Funding to support launch of its non-invasive ventilation (NIV) products in 2021. Tony Lair, the former CEO of NeoMed (acquired by Avanos), led the investment round with participation from existing and new investors, including Spring Bay Ventures and MedMountain Ventures. Tony Lair will join ReddyPort’s Board of Directors. […]
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers and is able to meet high demand. The test has recently received FDA emergency use authorization. “We are thrilled to have a point of care rapid antibody test now available. We know hospitals, medical offices, and other […]
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The test kit was developed to distinguish SARS-CoV-2 from other respiratory viruses, including influenza A/B and respiratory syncytial virus types A/B that may have similar symptoms. It runs on the firm’s Elite InGenius platform, as well as other […]
Both the House of Representatives and the Senate passed on Monday a more than $900 billion COVID-19 stimulus package. The long-awaited and much needed assistance comes after months of protracted wrangling between the parties. As of this writing, President Trump did not say he would veto the bill but he asked Congress to amend it […]
On January 7, join the three-hour event featuring topics such as company COVID responses, the pandemic’s impact on the real estate industry, innovations in life sciences, and more! Learn more and register here.
Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would include more funding for PPP loans, allow a second loan draw for hard-hit small businesses and streamline forgiveness for loans of $150,000 or less. In addition, the measure is expected to include some level of direct payments […]
12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine. Our goal to modernize cancer testing has taken us to exciting heights this year. We resolutely believe in our potential to introduce a ‘breakthrough’ Multi-Cancer Screen that will non-invasively detect the presence of malignancy in its earliest stages utilizing our Electrical Impedance Analytics […]
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]
Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19 vaccine. In addition to teachers, the first phase of vaccinations in Utah will focus on healthcare workers, as well as residents and staff of long-term care facilities. Last week, BioUtah sent a letter to the Utah Department […]
The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]
